Earnings Call · Q1 FY2023·2023-05-08

Q1 23EPS +100.00%*·Rev n/aQ4 22EPS +13.43%·Rev n/aQ3 22EPS +16.36%·Rev n/aQ2 22EPS -40.91%·Rev n/a⚠ consensus missing

ANI PHARMACEUTICALS INC ANIP

Judy DiClemente — Investor Relations

Nikhil Lalwani — President and Chief Executive Officer

Stephen Carey — Chief Financial Officer

+8.8%1d on move date+8.8% vs SPY3d+11.9%5d+6.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ANIP calls or request research access.

More ANIP calls Browse calls Request research access